A synthetic peptide from transforming growth factor β type III receptor inhibits liver fibrogenesis in rats with carbon tetrachloride liver injury-Reference-Cited by-同舟云学术

A synthetic peptide from transforming growth factor β type III receptor inhibits liver fibrogenesis in rats with carbon tetrachloride liver injury

Published:2003-04 Issue:1-2 Volume:22 Page:12-20
ISSN:1043-4666
Container-title:Cytokine
language:en
Short-container-title:Cytokine

Author:

Ezquerro Ignacio-José,Lasarte Juan-José,Dotor Javier,Castilla-Cortázar Inma,Bustos Matilde,Peñuelas Iván,Blanco Gemma,Rodrı́guez Carlos,Lechuga Marı́a del Carmen G.,Greenwel Patricia,Rojkind Marcos,Prieto Jesús,Borrás-Cuesta Francisco

Publisher

Elsevier BV

Subject

Molecular Biology,Hematology,Biochemistry,Immunology,Immunology and Allergy

Reference37 articles.

1. The transforming growth factor-beta family;Massague;Annu Rev Cell Biol,1990

2. Novel regulators of bone formation: molecular clones and activities;Wozney;Science,1988

3. TGF-beta receptor signaling;Derynck;Biochim Biophys Acta,1997

4. Inflammatory and immunomodulatory roles of TGF-beta;Wahl;Immunol Today,1989

5. Transforming growth factor-beta: an important mediator of immunoregulation;Kehrl;Int J Cell Cloning,1991

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structures of TGF-β with betaglycan and the signaling receptors reveal the mechanism whereby betaglycan potentiates receptor complex assembly and signaling;2024-07-22

2. Corneal fibrosis: From in vitro models to current and upcoming drug and gene medicines;Advanced Drug Delivery Reviews;2024-06

3. TGF-β signaling in health, disease and therapeutics;Signal Transduction and Targeted Therapy;2024-03-22

4. Quercetin inhibits mesothelial-mesenchymal transition and alleviates postoperative peritoneal adhesions by blocking the TGF-β1/PI3K/AKT pathway;Journal of Ethnopharmacology;2024-01

5. Assessment of the effectiveness of the peptide inhibitor homologous to the transforming growth factor β cytokine blocking the TGFβRI/TGFβRII receptor complex—pilot study;Clinical and Translational Allergy;2023-12-31